# Immix Biopharma, Inc.

**Source:** https://www.startuphub.ai/startups/immix-biopharma
**Profile type:** Startup

> A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

## About

Immix Biopharma is a biopharmaceutical company developing a revolutionary one-time CAR-T therapy, NXC-201, designed to re-engineer the immune system to fight AL Amyloidosis. This therapy targets diseased cells, aiming to normalize disease within days and provide a durable response with minimal side effects, particularly for vulnerable patients with heart involvement. Immix Biopharma is focused on creating medicines that are both effective and safe, addressing the critical unmet need for relapsed/refractory AL amyloidosis patients.

## Key facts

- **Slug:** immix-biopharma
- **Website:** https://immixbio.com
- **Location:** Los Angeles, United States
- **Employees:** 53
- **Operating status:** Active
- **Total funding:** $5M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials, Cell Therapy, Oncology, Immunology, Rare Disease
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/immix-biopharma
  - Facebook: https://www.facebook.com/ImmixBiopharma

## Frequently asked

### What does Immix Biopharma, Inc. do?

Immix Biopharma is a biopharmaceutical company developing a revolutionary one-time CAR-T therapy, NXC-201, designed to re-engineer the immune system to fight AL Amyloidosis. This therapy targets diseased cells, aiming to normalize disease within days and provide a durable response with minimal side effects, particularly for vulnerable patients with heart involvement. Immix Biopharma is focused on creating medicines that are both effective and safe, addressing the critical unmet need for relapsed…

### How much funding has Immix Biopharma, Inc. raised?

Immix Biopharma, Inc. has raised a total of $5M in funding. The most recent round on record is At-The-Market Equity Offering.

### Where is Immix Biopharma, Inc. headquartered?

Immix Biopharma, Inc. is headquartered in Los Angeles, United States.

### What industry does Immix Biopharma, Inc. operate in?

Immix Biopharma, Inc. operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech.

### How many employees does Immix Biopharma, Inc. have?

Immix Biopharma, Inc. has approximately 53 people on record.

### What is Immix Biopharma, Inc.'s revenue?

StartupHub estimates Immix Biopharma, Inc.'s annual revenue at $5.4M (range $2.9M to $15.9M, 69% confidence), based on comparable companies in the sector.

### What is Immix Biopharma, Inc.'s valuation?

StartupHub estimates Immix Biopharma, Inc.'s effective valuation at $20.0M (range $12.5M to $30.0M, 12% confidence), based on comparable companies in the sector.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Immix Biopharma, Inc.",
          "item": "https://www.startuphub.ai/startups/immix-biopharma"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/immix-biopharma#webpage",
      "url": "https://www.startuphub.ai/startups/immix-biopharma",
      "name": "Immix Biopharma, Inc. - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Immix Biopharma, Inc.. Immix Biopharma, Inc. is a startup operating in Biotechnology and Pharmaceuticals. A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases. Headquartered in Los Angeles, United States. The company has approximately 53 employees.",
      "dateModified": "2026-07-22T00:05:26.716+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/immix-biopharma#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/immix-biopharma#organization",
      "name": "Immix Biopharma, Inc.",
      "url": "https://immixbio.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/immix-biopharma-square-from-og.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/immix-biopharma-square-from-og.webp",
      "description": "This is the official profile of Immix Biopharma, Inc.. Immix Biopharma, Inc. is a startup operating in Biotechnology and Pharmaceuticals. A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases. Headquartered in Los Angeles, United States. The company has approximately 53 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/immix-biopharma",
        "https://www.facebook.com/ImmixBiopharma",
        "https://www.startuphub.ai/startups/immix-biopharma"
      ],
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 53
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Los Angeles",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare",
        "Biotech",
        "MedTech",
        "HealthTech",
        "Genomics",
        "Drug Discovery",
        "Clinical Trials",
        "Cell Therapy",
        "Oncology",
        "Immunology",
        "Rare Disease"
      ]
    }
  ]
}
```